Arrhythmias & electrophysiologyResearch article

Atrial Fibrillation Burden and Clinical Outcomes After Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs

JACC AdvPublished

  • per-protocol analysis

Authors' conclusion

In this per-protocol analysis, CA resulted in superior rhythm control compared with LFM + AAD therapy. AF burden reduction was accompanied by fewer AF-related hospitalizations or emergency visits. (PRAGUE-25 Trial: Catheter Ablation vs. AADs and Risk Factor Modification; NCT04011800).

Study context

Population
Obese patients with atrial fibrillation (AF)randomized, 96 catheter ablation (CA) and 83 LFM + AAD patients included in the per-protocol analysis · CA 96 · LFM + AAD 83
Participants
203 patients
Comparison
CA vs LFM + AAD per-protocol populations
  • CAn = 96
  • LFM + AADn = 83

Main finding

As reported in the abstract

Baseline AF burden · baseline

P = 0.39

Further findings

AF-related hospitalizations or emergency visits · during the study course

P = 0.026

Major adverse cardiovascular events (composite of stroke, cardiovascular death, or heart failure hospitalization) · during the study course · rare and similar between groups

P = 0.99

OutcomeP value
AF burden · 6, 9, and 12 months · lower in the CA groupall P < 0.001

Baseline characteristics

Mean age
60 ± 9 years
Men
68.5%
Mean body mass index
35 ± 3 kg/m²

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Atrial Fibrillation Burden and Clinical Outcomes After Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs. JACC Adv. Published 6 August 2026. doi:10.1016/j.jacadv.2026.103109

Summarised from the published abstract; every number is checked against it